MDROs are particularly concerning in healthcare settings because they can spread rapidly among vulnerable populations, such as the elderly, immunocompromised patients, and those with chronic diseases. The reduced efficacy of standard antibiotics necessitates the use of more toxic, expensive, and less effective alternative treatments, which can lead to longer hospital stays and higher healthcare costs.
